Journal
IMMUNOBIOLOGY
Volume 216, Issue 12, Pages 1256-1263Publisher
ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.imbio.2011.07.006
Keywords
Anti-TNF; NK cells; Regulatory T cells; Rheumatoid arthritis; Th17 cells
Categories
Funding
- Fondecyt-Chile [1090174]
- Millennium Institute on Immunology and Immunotherapy [P09-016-F]
- Conicyt
Ask authors/readers for more resources
The aim of this work was to study the effect of anti-TNF treatment on CD4+Th1, Th17 and regulatory T cells (Tregs), together with CD8+ T cells and NK cells from rheumatoid arthritis (RA) patients. For this purpose, 18 RA patients received adalimumab during 16 weeks and their peripheral blood lymphocytes were assessed by flow cytometry at the beginning and at the end of the study. We found that the proportion of Th17 cells was directly correlated with Th1 cells, but inversely correlated with IFN-gamma-producing NK cells. A decrease was observed in Th1, Th17 cells and IFN-gamma-producing CD8+ T cells by anti-TNF therapy. Conversely, the proportion of Tregs increased, as did the percentage of IFN-gamma-producing NK cells. We postulate that a rise in IFN-gamma production due to recovery of NK cells' function, together with expanded Tregs, contribute to decrease the Th17 response in anti-TNF-treated RA patients. (C) 2011 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available